Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells
- 7 December 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (51), 22255-22259
- https://doi.org/10.1073/pnas.1009633108
Abstract
The G protein-coupled receptor (GPCR), chemokine CXC-type receptor 4 (CXCR4), and its ligand, CXCL12, mediate the retention of polymorphonuclear neutrophils (PMNs) and hematopoietic stem and progenitor cells (HSPCs) in the bone marrow. Agents that disrupt CXCL12-mediated chemoattraction of CXCR4-expressing cells mobilize PMNs and HSPCs into the peripheral circulation and are therapeutically useful for HSPC collection before autologous bone marrow transplantation (ABMT). Our aim was to develop unique CXCR4-targeted therapeutics using lipopeptide GPCR modulators called pepducins. A pepducin is a synthetic molecule composed of a peptide derived from the amino acid sequence of one of the intracellular (IC) loops of a target GPCR coupled to a lipid tether. We prepared and screened a small CXCR4-targeted pepducin library and identified several pepducins with in vitro agonist activity, including ATI-2341, whose peptide sequence derives from the first IC loop. ATI-2341 induced CXCR4- and G protein-dependent signaling, receptor internalization, and chemotaxis in CXCR4-expressing cells. It also induced dose-dependent peritoneal recruitment of PMNs when administered i.p. to mice. However, when administered systemically by i.v. bolus, ATI-2341 acted as a functional antagonist and dose-dependently mediated release of PMNs from the bone marrow of both mice and cynomolgus monkeys. ATI-2341–mediated release of granulocyte/macrophage progenitor cells from the bone marrow was confirmed by colony-forming assays. We conclude that ATI-2341 is a potent and efficacious mobilizer of bone marrow PMNs and HSPCs and could represent a previously undescribed therapeutic approach for the recruitment of HSPCs before ABMT.Keywords
This publication has 25 references indexed in Scilit:
- Plerixafor (Mozobil®) Alone to Mobilize Hematopoietic Stem Cells from Multiple Myeloma Patients for Autologous TransplantationTransplantation and Cellular Therapy, 2010
- Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and MetastasisCancer Research, 2009
- The structure and function of G-protein-coupled receptorsNature, 2009
- Neutrophil mobilization and clearance in the bone marrowImmunology, 2008
- Anticoagulant and antithrombotic properties of intracellular protease‐activated receptor antagonistsJournal of Thrombosis and Haemostasis, 2007
- The Many Facets of SDF-1, CXCR4 Agonists and Antagonists on Hematopoietic Progenitor CellsJournal of Biomedicine and Biotechnology, 2007
- Regulation of CXCR4 signalingBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Protease-Activated Receptors in Cardiovascular DiseasesCirculation, 2006
- CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironmentBlood, 2006
- Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonistThe Journal of Experimental Medicine, 2005